HO CHI MINH CITY, June 30, 2023, Pfizer is one of the world's premier innovative biopharmaceutical companies. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines.
Pfizer has been focusing our business where we believe we can have the greatest impact on patients and society – pursuing what we believe to be the most innovative biopharmaceutical therapies (for example in Oncology, Rare Disease, Internal Medicine, Anti-infectives, Immunology etc.) and vaccines. Pfizer is “all in” on our purpose – Breakthroughs that change patients’ lives – by putting even more breakthroughs in Vietnamese patients’ hands. (Learn more)
All product names, whether appearing in large print or with the trademark symbol, are trademarks of Pfizer, its affiliates, related companies or its licensors or joint venture partners, unless otherwise noted.
We have not authorized Pfizer company's logo and trademark to be used by any other production and business activities in Vietnam. The use or misuse of these trademarks or any other materials, except as permitted herein, is expressly prohibited and may be in violation of copyright law, trademark law, the law of slander and libel, the law of privacy and publicity, law on consumer rights protection and communications regulations and statutes.
We remain focus to bring breakthroughs for patients and deliver on the value of science and healthcare. We reiterate that Pfizer is focused on our core business in biopharmaceuticals, and not associated with any other industry in Vietnam.
Pfizer has two main business locations at Ho Chi Minh City and Ha Noi City in Vietnam. Visit our website https://www.pfizer.com.vn/en/contact-us to know more about our company and business operations in Vietnam.
Kindly take note that industry regulations do not allow pharmaceutical companies to offer medical advice or guidance to consumers or patients. Please contact your doctor or healthcare professional for advice on medicines or any heath related matters.
Disclosure Notice
The information contained in this release is as of Jun 30, 2023. Pfizer assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or developments.
Media Contact
Minh Ha Ho
+84 987 530 219
Minh.Ho@pfizer.com